Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$781M |
| 2 |
Amazon
AMZN
|
+$728M |
| 3 |
AABA
Altaba Inc
AABA
|
+$535M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$296M |
| 5 |
Booking.com
BKNG
|
+$274M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$353M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$261M |
| 3 |
Alibaba
BABA
|
+$228M |
| 4 |
Citigroup
C
|
+$170M |
| 5 |
DuPont de Nemours
DD
|
+$165M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.03% |
| 2 | Consumer Discretionary | 1.46% |
| 3 | Financials | 1.01% |
| 4 | Healthcare | 0.92% |
| 5 | Communication Services | 0.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
CALL
Yum China
YUMC
$16.6B
| $24.4M | 0.01% |
618,800
+213,300
| +53% | +$7.7M |
|
|
PTLA
1002
CALL
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $24.4M | 0.01% |
434,300
+183,800
| +73% | +$7.36M |
|
1003
CALL
Ambarella
AMBA
$3.1B
| $24.4M | 0.01% |
502,400
-25,500
| -5% | -$1.41M |
|
|
MNDT
1004
CALL
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $24.3M | 0.01% |
1,600,500
-1,223,300
| -43% | -$17.4M |
|
1005
CALL
Deutsche Bank
DB
$73.4B
| $24.3M | 0.01% |
1,367,200
-944,400
| -41% | -$16.7M |
|
1006
PUT
Thor Industries
THO
$4.14B
| $24.3M | 0.01% |
232,500
+73,500
| +46% | +$7.12M |
|
1007
PUT
Under Armour Class C
UA
$2.15B
| $24.3M | 0.01% |
1,205,300
-249,000
| -17% | -$4.69M |
|
1008
PUT
Snap-on
SNA
$20.4B
| $24.3M | 0.01% |
153,700
+70,400
| +85% | +$11.5M |
|
1009
PUT
Omega Healthcare
OHI
$14.2B
| $24.3M | 0.01% |
734,900
+418,100
| +132% | +$13.8M |
|
|
1010
Deutsche Bank
DB
$73.4B
| $24.3M | 0.01% |
1,363,500
-2,240,150
| -62% | -$39.6M |
|
1011
Illumina
ILMN
$34B
| $24.1M | 0.01% |
+142,855
| New | +$24.7M |
|
1012
Universal Display
OLED
$4.11B
| $24M | 0.01% |
220,104
+183,533
| +502% | +$19.3M |
|
1013
CALL
McCormick & Company Non-Voting
MKC
$14.6B
| $24M | 0.01% |
492,400
+338,800
| +221% | +$17.1M |
|
|
MRO
1014
PUT
DELISTED
Marathon Oil Corporation
MRO
| $24M | 0.01% |
2,025,200
+457,200
| +29% | +$6.4M |
|
1015
CALL
Ionis Pharmaceuticals
IONS
$10.6B
| $23.9M | 0.01% |
469,000
-61,200
| -12% | -$2.85M |
|
1016
CALL
Alnylam Pharmaceuticals
ALNY
$32.1B
| $23.8M | 0.01% |
298,100
+26,300
| +10% | +$1.68M |
|
1017
CALL
HF Sinclair
DINO
$16.6B
| $23.8M | 0.01% |
865,300
+68,900
| +9% | +$1.84M |
|
1018
CALL
Archer Daniels Midland
ADM
$38.2B
| $23.8M | 0.01% |
574,200
+187,600
| +49% | +$8.05M |
|
|
TIF
1019
CALL
DELISTED
Tiffany & Co.
TIF
| $23.7M | 0.01% |
252,900
-260,300
| -51% | -$23.9M |
|
1020
CALL
Prologis
PLD
$136B
| $23.6M | 0.01% |
403,200
+53,600
| +15% | +$2.98M |
|
1021
CALL
iShares Core S&P 500 ETF
IVV
$894B
| $23.6M | 0.01% |
97,100
-61,000
| -39% | -$14.7M |
|
1022
CALL
State Street Materials Select Sector SPDR ETF
XLB
$8.88B
| $23.6M | 0.01% |
877,600
-49,200
| -5% | -$1.31M |
|
1023
Mastercard
MA
$525B
| $23.6M | 0.01% |
194,244
-123,934
| -39% | -$14.7M |
|
1024
PUT
Becton Dickinson
BDX
$51.7B
| $23.6M | 0.01% |
123,923
+35,568
| +40% | +$6.5M |
|
1025
CALL
Illinois Tool Works
ITW
$80.2B
| $23.6M | 0.01% |
164,400
-130,200
| -44% | -$18.2M |
|
Similar funds
Jeff Yass's Q2 2017 Portfolio in Review
As of Q2 2017, Jeff Yass held 10,525 positions worth $228B, up 15% from $198B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Jeff Yass deployed $21.5B of net new capital in Q2 2017, opening 1,702 new positions and adding to 3,804 existing holdings. Its largest new stake was Altaba Inc: 9,835,232 shares worth $536M.
By sector, the portfolio is most concentrated in Technology at 2% of assets, up from 1.2% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $353M trimmed.
- Jeff Yass's largest Q2 2017 buy was Altaba Inc: 9,835,232 shares worth $536M.
- Jeff Yass added most to Apple in Q2 2017, an estimated $781M increase.
- Jeff Yass's biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $353M.
- Jeff Yass fully exited Alphabet (Google) Class C in Q2 2017, selling an estimated $261M.
- Jeff Yass's ten largest holdings make up 22% of its $228B portfolio in Q2 2017.
- Jeff Yass opened 1,702 new positions and closed 1,419 in Q2 2017.
- Jeff Yass's portfolio value rose 15% quarter-over-quarter to $228B.
Based on Susquehanna International Group's 13F filing for Q2 2017, filed 15 Aug 2017.